| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |